PACEPro - Mood Management Pilot

• Status: Completed
• Trial end date: 2007-01-01
• Target enrollment: 0
• Participant gender: All

Summary

Researchers at the University of California at San Diego (UCSD) are conducting a 12-week study to test the PACEPRO program. This program is designed to reduce depression by providing:

Lexapro, an antidepressant medicine…Learn More Physical activity information and pedometer Mood management skills and a Mood Mastery Guide Personalized support from a Family Nurse Practitioner

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of California, San Diego
• Collaborator: Forest Laboratories
• Treatments: Antidepressive Agents; Citalopram; Dexetimide

Criteria

Inclusion Criteria:

• Have been diagnosed with mild to moderate depression

• Are willing to take the antidepressant Lexapro

• Can access and use Email and the Internet

• Are willing and able to be physically active

• Access to a primary care physician

Exclusion Criteria:

Subjects will be excluded from participation for the following reasons:

• Pregnancy or breastfeeding

• Narrow angle glaucoma

• Any uncontrolled medical condition or any medical condition which would represent a contraindication to Escitalopram Oxalate Lexapro® pharmacotherapy. Any concomitant non-psychotropic medications that the physician determines are a contraindication to Escitalopram Oxalate Lexapro® pharmacotherapy Bipolar disorder, or any psychotic or organic mental disorder or dementia

• History of intolerance or allergy to Lexapro, or of prior failed treatment for depression with Lexapro

• Current substance abuse or dependency

• Current active suicidal ideation

• Current use of herbal psychoactive treatments such as St. John's Wort

• Concurrent psychotropic medication is not permitted for 2 weeks prior to randomization (4 weeks in the case of fluoxetine) or at any point after

• Receipt of formal psychotherapy concurrently

• Inability, in the investigator's opinion, to comply with study procedures or assessments

• Inability to exercise